X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8582) 8582
Publication (1298) 1298
Paper (243) 243
Patent (235) 235
Book Chapter (122) 122
Conference Proceeding (96) 96
Book Review (76) 76
Newspaper Article (41) 41
Magazine Article (25) 25
Dissertation (20) 20
Book / eBook (14) 14
Technical Report (13) 13
Government Document (3) 3
Trade Publication Article (3) 3
Reference (2) 2
Streaming Video (2) 2
Data Set (1) 1
Newsletter (1) 1
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3564) 3564
humans (3479) 3479
male (2095) 2095
female (1974) 1974
animals (1443) 1443
middle aged (1203) 1203
adult (1097) 1097
research (973) 973
aged (942) 942
analysis (846) 846
article (736) 736
research article (563) 563
oncology (541) 541
mice (523) 523
risk factors (515) 515
multidisciplinary sciences (504) 504
cancer (498) 498
health aspects (481) 481
medicine (475) 475
care and treatment (446) 446
neurosciences (440) 440
treatment outcome (431) 431
adolescent (411) 411
proteins (410) 410
medicine & public health (382) 382
surgery (380) 380
studies (379) 379
physiological aspects (361) 361
aged, 80 and over (352) 352
biochemistry & molecular biology (352) 352
clinical neurology (347) 347
physics (336) 336
science (326) 326
biology (325) 325
expression (324) 324
genetic aspects (321) 321
gene expression (320) 320
cell biology (315) 315
genetics & heredity (315) 315
usage (309) 309
retrospective studies (296) 296
young adult (286) 286
child (280) 280
genetics (280) 280
microbiology (275) 275
risk (275) 275
diagnosis (271) 271
life sciences (271) 271
time factors (271) 271
abridged index medicus (270) 270
mortality (269) 269
chemistry (268) 268
immunology (262) 262
medical research (255) 255
mutation (254) 254
experiment (248) 248
rats (248) 248
pharmacology & pharmacy (243) 243
cardiac & cardiovascular systems (240) 240
particle physics (239) 239
therapy (239) 239
patients (235) 235
disease (233) 233
pediatrics (230) 230
genes (225) 225
genomes (225) 225
genomics (222) 222
high energy physics - experiment (222) 222
physiology (218) 218
children (209) 209
physics - high energy physics - experiment (209) 209
ecology (207) 207
management (205) 205
respiratory system (200) 200
prevalence (198) 198
palladium (196) 196
inflammation (194) 194
methods (194) 194
endocrinology & metabolism (193) 193
psychiatry (191) 191
chemotherapy (189) 189
physics, particles & fields (188) 188
chemistry, multidisciplinary (186) 186
epidemiology (186) 186
survival (186) 186
biotechnology & applied microbiology (185) 185
follow-up studies (185) 185
physics of elementary particles and fields (183) 183
tumors (183) 183
clinical trials (182) 182
prospective studies (182) 182
molecular sequence data (181) 181
brain (180) 180
disease models, animal (179) 179
magnetic resonance imaging (179) 179
medicine, general & internal (179) 179
prognosis (174) 174
metabolism (173) 173
infectious diseases (172) 172
parkinson's disease (167) 167
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Media Commons - Microtexts (3) 3
Gerstein Science - Stacks (2) 2
Robarts - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Theses (1) 1
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Thomas Fisher Rare Book - May be requested at Fisher (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9044) 9044
French (66) 66
German (32) 32
Chinese (18) 18
Spanish (16) 16
Japanese (9) 9
Portuguese (9) 9
Korean (3) 3
Arabic (1) 1
Bulgarian (1) 1
Czech (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1823 - 1833
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1540 - 1550
Summary Background Despite recent advances in the treatment of advanced non-small-cell lung cancer, there remains a need for effective treatments for... 
Internal Medicine | CRITERIA | MEDICINE, GENERAL & INTERNAL | ANTI-PD-L1 ANTIBODY | THERAPY | NSCLC | IMMUNOTHERAPY | PD-L1 | BLOCKADE | NIVOLUMAB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - chemistry | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Patient Selection | Taxoids - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Agents - adverse effects | Adult | Female | Taxoids - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Lung Neoplasms - chemistry | Docetaxel | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Taxoids - administration & dosage | Aged | B7-H1 Antigen - analysis | Carcinoma, Non-Small-Cell Lung - drug therapy | Antimitotic agents | Medical colleges | Lung cancer, Non-small cell | Antineoplastic agents | Analysis | Chemotherapy | Biopsy | Genes | Lung cancer | Clinical trials | Oncology | Mutation | Tumors | Cell survival | Medical treatment | FDA approval | Health care facilities | Survival | Patients | Evidence-based medicine | Pembrolizumab | Randomization | Interactive systems | Immunotherapy | Risk assessment | PD-L1 protein | Biomarkers
Journal Article
BJU International, ISSN 1464-4096, 04/2017, Volume 119, Issue 4, pp. 579 - 584
Journal Article
Chemistry – A European Journal, ISSN 0947-6539, 06/2006, Volume 12, Issue 18, pp. 4743 - 4748
The synthesis of NHC‐PdCl2‐3‐chloropyridine (NHC=N‐heterocyclic carbene) complexes from readily available starting materials in air is described. The... 
palladium | alkanes | heterocycles | CC coupling | C-C coupling | Heterocycles | Alkanes | Palladium | REDUCTIVE ELIMINATION | CHEMISTRY, MULTIDISCIPLINARY | ALKYL-HALIDES | BORONIC ACIDS | ALCOHOLS | CROSS-COUPLING REACTIONS | AMINATION | LIGANDS | OXIDATIVE-ADDITION | CATALYTIC-ACTIVITY | ARYL CHLORIDES
Journal Article
by Mok, Tony S K and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Cho, Byoung Chul and Turna, Hande Z and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Kush, Debra and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Bondarenko, Igor and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Castro, Gilberto and Castro, Hugo and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Gongyan and Chen, Xi and Cheng, Susanna and Cheng, Ying and Cherciu, Nelly and Chiu, Chao-Hua and Cho, Byoung Chul and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Jianxing and He, Yong and Hernandez Hernandez, Carlos and Hespanhol, Venceslau and Hirashima, Tomonori and Ho, Chung Man James and Horiike, Atsushi and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Lung cancer | Oncology | Kinases | Cancer therapies | Evidence-based medicine | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Health care facilities | Hypothyroidism | Survival | Patients | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis
Journal Article
Journal Article
Gut, ISSN 0017-5749, 02/2018, Volume 67, Issue 2, pp. 320 - 332
ObjectiveLimited efficacy of immune checkpoint inhibitors in pancreatic ductal adenocarcinoma (PDAC) has prompted investigation into combination therapy. We... 
INTERLEUKINS | IMMUNOTHERAPY | PANCREATIC CANCER | MULTIPLE-MYELOMA | INTERFERON-ALPHA | ACTIVATION | ADENOCARCINOMA | SILTUXIMAB | MONOCLONAL-ANTIBODY | MICE | SUPPRESSOR-CELLS | INTERLEUKIN-6 | GASTROENTEROLOGY & HEPATOLOGY | T-CELLS | Antineoplastic Agents, Immunological - administration & dosage | Interleukin-6 - antagonists & inhibitors | Pancreatic Neoplasms - metabolism | Humans | Actins - metabolism | Carcinoma, Pancreatic Ductal - metabolism | STAT Transcription Factors - metabolism | Janus Kinases - metabolism | L-Selectin - metabolism | Pancreatic Neoplasms - drug therapy | Th1 Cells - metabolism | Pancreatic Stellate Cells - immunology | Hyaluronan Receptors - metabolism | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Carcinoma, Pancreatic Ductal - immunology | Interleukin-6 - metabolism | Disease Models, Animal | Mice, Inbred C57BL | Survival Rate | B7-H1 Antigen - immunology | Disease Progression | Tumor Microenvironment - immunology | Xenograft Model Antitumor Assays | Carcinoma, Pancreatic Ductal - drug therapy | B7-H1 Antigen - metabolism | Animals | B7-H1 Antigen - antagonists & inhibitors | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pancreatic Neoplasms - immunology | Interleukin-6 - immunology | Mice | Pancreatic Stellate Cells - metabolism | Adenocarcinoma | Immunohistochemistry | Flow cytometry | Animal models | Transcription | CD8 antigen | Multiple myeloma | Smooth muscle | Lymphocytes T | Kinases | Metastases | Interleukin 6 | Lymphocytes | Actin | CD44 antigen | Immunotherapy | Fibroblasts | BRCA2 protein | Stellate cells | Cytokines | Stroma | CD62L protein | CD4 antigen | Immune checkpoint | Antibiotics | Pancreatic cancer | Medical prognosis | PD-L1 protein | Ligands | Genetic engineering | Apoptosis | PD-L1 | pancreatic cancer | IL-6
Journal Article